Predict | HEOR & Real World Outcomes

Gain precision insights for product and population outcomes.

The business of life sciences R&D is fundamentally shifting – from a focus on approval to a broader view on widespread adoption by providers and payers, from proving value in controlled, clinical settings to demonstrating it in target populations and real-world conditions. Gain insights into the patients that benefit from your products and learn how to distinguish who achieves significantly better outcomes than others. Employ AI-enriched profiles to define  precision cohorts and understand the medical and social factors that impact the patient journey and access to therapy.

AI INFORMS ACTION

Understand the health economics and data-driven outcomes for important therapeutic areas.

ClosedLoop generates explainable predictions using thousands of auto-generated, clinically relevant contributing factors.

Distinguish

Distinguish who achieves significantly better outcomes than others and refine key subpopulations, segmentation and targeting capabilities

Surface

Surface hard-to-identify patients and under-penetrated segments by applying specific inclusion and exclusion criteria

Assess

Assess health disparities and pinpoint patients who might benefit from medication assistance programs, targeted education, delivery services, adherence reminders, or medication management

EXPLORE MORE USE CASES

Digital Therapeutics

Pharma

Maximize solution value and measure success.

Emergency Room Visits & Observation Stays

Payers

Providers

Reduce ER visits and enhance continuity of care.

Length of Stay

Providers

Reduce length of stay and improve outcomes.

Make AI/ML a core element of your care strategy.

Get in touch today to see the ClosedLoop platform in action.